Skip to content

Ayurvedic Management Of Sciatica (Gridhrasi) through Therapeutic enema and blood letting

Comparative Study Of Basti Karma and Siravedha in the management of Gridhrasi (Sciatica)

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/02/011909
Enrollment
60
Registered
2018-02-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M472- Other spondylosis with radiculopathy Health Condition 2: null- Suffering from Gridhrasi (Sciatica)

Interventions

Intervention1: Siravedha Karma: Siravedha will be done under aseptic conditions with the help of Scalp Vein No.20 at the site of antrakandra gulfa ( at the moddle of ankle on superficial veins of leg

Sponsors

Ch Brahm Prakash Ayurved Charak Sansthan
Lead Sponsor
PG Department Of Panchkarma
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1.Presence of Ruka, Toda, stambha and Spandana in the sphik, kati, uru, janu, jangha and Pada. 2.Tenderness along the course of Sciatic Nerve. 3.Patients of either sex between age group of 20years to 50years will be included. 4. SLR test in affected leg as objective measure for diagnosis and assessment.

Exclusion criteria

Exclusion criteria: 1.Contraindicated for Basti Karma and Siravedha 2.known cases of any major illness e.g. DM,TB,AIDS,Malignancy 3. Surgical indications such as progressive neurological deficit 4. Pregnancy 5. Anaemia 6. Patients having skin infections

Design outcomes

Primary

MeasureTime frame
Remission of sign and symptoms upto 60-80%Timepoint: 60 Days

Secondary

MeasureTime frame
Patient quality of life will be improvedTimepoint: 60 Days

Countries

India

Contacts

Public ContactDr Pankaj Sharma

Ch. Brahm Prakash Ayurved Charak Sansthan

vishakhawetal@gmail.com9518528493

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026